UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.64-64

2022

Volltextzugriff (PDF)

An uncommon complication of vertebroplasty: the role of anticoagulation

Anti-cancer drugs, 2019-07, Vol.30 (6), p.646-648

2019

Volltextzugriff (PDF)

Abstract 463: Features consistent with a small-cell neuroendocrine like (SC/NE-L) transformation can be readily detected and quantified in circulating tumor cells (CTCs)

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.463-463

2021

Volltextzugriff (PDF)

Abstract P5-16-08: Phase Ib/II trial evaluating safety and efficacy of copanlisib (PI3K inhibitor) and trastuzumab in pre-treated advanced HER2-positive breast cancer: Results from the PantHER study

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P5-P5-16-08

2022

Volltextzugriff (PDF)

Neoadjuvant pertuzumab, T-DM1, weekly paclitaxel and possible anthracyclines in HER2 positive early breast cancer treatment—questions from the KRISTINE study

Translational cancer research, 2018-06, Vol.7 (S5), p.S562-S567

2018

Volltextzugriff (PDF)

Abstract P1-19-24: A phase Ib trial of copanlisib in combination with trastuzumab in pretreated recurrent or metastatic HER2-positive breast cancer “PantHER”

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P1-P1-19-24

2020

Volltextzugriff (PDF)

Does interval from histologic diagnosis (Dx) to start of chemotherapy (Ctx) impact survival in metastatic colorectal cancer (MCRC)?

Journal of clinical oncology, 2014-01, Vol.32 (3_suppl), p.615-615

2014

Volltextzugriff (PDF)

Abstract 941: Assessment of the completeness, accuracy, and scalability of commercial abstraction for a large prostate cancer biospecimen repository

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.941-941

2023

Volltextzugriff (PDF)

Durable clinical benefit from combination ipilimumab (IPI) and nivolumab (NIVO) in anti-PD-1 therapy resistant, platinum resistant metastatic urothelial carcinoma (mUC)

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.481-481

2019

Volltextzugriff (PDF)

Evaluating the Learning Curve of Magnetic Resonance Imaging (MRI) as a Predictive Tool in Locally Advanced Rectal Cancer (RC) - a Retrospective 12-Year Experience

Annals of oncology, 2014-06, Vol.25, p.ii80-ii80

2014

Volltextzugriff (PDF)

Identifying factors to predict benefit from bevacizumab in progressive glioblastoma multiforme (GBM)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e13515-e13515

2017

Volltextzugriff (PDF)

Effect of TCHL-based therapy on immune cell content in on-treatment, neoadjuvant-treated HER2-positive breast cancer patients

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.583-583

2017

Volltextzugriff (PDF)

A phase Ib trial of copanlisib and tratuzumab in pretreated recurrent or metastatic HER2-positive breast cancer “PantHER”

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1036-1036

2018

Volltextzugriff (PDF)

Sunitinib scheduling in metastatic renal cell cancer: A single-center experience

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.554-554

2016

Volltextzugriff (PDF)

Evaluating magnetic resonance imaging (MRI) as a positive predictive tool in locally advanced rectal cancer (RC): A retrospective 12-year experience

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e14568-e14568

2014

Volltextzugriff (PDF)

Low oncotype recurrence score (RS) and poor clinical outcomes: An irish multicentre experience

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e11586-e11586

2015

Volltextzugriff (PDF)

Comparing attitudes of younger and older patients towards cancer clinical trials

Journal of geriatric oncology, 2016-05, Vol.7 (3), p.162-168

2016

Volltextzugriff (PDF)

Attitudes of patients towards cancer clinical trials

Journal of clinical oncology, 2015-01, Vol.33 (3_suppl), p.741-741

2015

Volltextzugriff (PDF)

ICORG 10-14: Neo-AEGIS: A randomized clinical trial of neoadjuvant and adjuvant chemotherapy (modified MAGIC regimen) versus neoadjuvant chemoradiation (CROSS protocol) in adenocarcinoma of the esophagus and esophagogastric junction

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.TPS4145-TPS4145

2014

Volltextzugriff (PDF)

The RNA-Editing Enzyme ADAR1 Controls Innate Immune Responses to RNA

Cell reports (Cambridge), 2014-11, Vol.9 (4), p.1482-1494

2014

Volltextzugriff (PDF)

The Epitranscriptome and Innate Immunity

PLoS genetics, 2015-12, Vol.11 (12), p.e1005687-e1005687

2015

Volltextzugriff (PDF)

Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates

PloS one, 2011-04, Vol.6 (4), p.e17600

2011

Volltextzugriff (PDF)

Dynamic actuation enhances transport and extends therapeutic lifespan in an implantable drug delivery platform

Nature communications, 2022-08, Vol.13 (1), p.4496-4496, Article 4496

2022

Volltextzugriff (PDF)

New Insights into the Biological Role of Mammalian ADARs; the RNA Editing Proteins

Biomolecules (Basel, Switzerland), 2015-09, Vol.5 (4), p.2338-2362

2015

Volltextzugriff (PDF)

Usher Syndrome on the Island of Ireland: A Genotype-Phenotype Review

Investigative ophthalmology & visual science, 2023-07, Vol.64 (10), p.23-23

2023

Volltextzugriff (PDF)

26 – 50 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(65)
Reviews
(1)

Sprache

Englisch
(66)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(16)
Cancer Research
(4)
Frontiers In Surgery
(3)
Cancers
(2)
Genes
(2)
Plos Genetics
(2)
Plos One
(2)
Advances In Experimental Medicine And Biology
(1)
Annals Of Oncology
(1)
Anti-Cancer Drugs
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality

An uncommon complication of vertebroplasty: the role of anticoagulation

Abstract 463: Features consistent with a small-cell neuroendocrine like (SC/NE-L) transformation can be readily detected and quantified in circulating tumor cells (CTCs)

Abstract P5-16-08: Phase Ib/II trial evaluating safety and efficacy of copanlisib (PI3K inhibitor) and trastuzumab in pre-treated advanced HER2-positive breast cancer: Results from the PantHER study

Neoadjuvant pertuzumab, T-DM1, weekly paclitaxel and possible anthracyclines in HER2 positive early breast cancer treatment—questions from the KRISTINE study

Abstract P1-19-24: A phase Ib trial of copanlisib in combination with trastuzumab in pretreated recurrent or metastatic HER2-positive breast cancer “PantHER”

Does interval from histologic diagnosis (Dx) to start of chemotherapy (Ctx) impact survival in metastatic colorectal cancer (MCRC)?

Abstract 941: Assessment of the completeness, accuracy, and scalability of commercial abstraction for a large prostate cancer biospecimen repository

Durable clinical benefit from combination ipilimumab (IPI) and nivolumab (NIVO) in anti-PD-1 therapy resistant, platinum resistant metastatic urothelial carcinoma (mUC)

Evaluating the Learning Curve of Magnetic Resonance Imaging (MRI) as a Predictive Tool in Locally Advanced Rectal Cancer (RC) - a Retrospective 12-Year Experience

Identifying factors to predict benefit from bevacizumab in progressive glioblastoma multiforme (GBM)

Effect of TCHL-based therapy on immune cell content in on-treatment, neoadjuvant-treated HER2-positive breast cancer patients

A phase Ib trial of copanlisib and tratuzumab in pretreated recurrent or metastatic HER2-positive breast cancer “PantHER”

Sunitinib scheduling in metastatic renal cell cancer: A single-center experience

Evaluating magnetic resonance imaging (MRI) as a positive predictive tool in locally advanced rectal cancer (RC): A retrospective 12-year experience

Low oncotype recurrence score (RS) and poor clinical outcomes: An irish multicentre experience

Comparing attitudes of younger and older patients towards cancer clinical trials

Attitudes of patients towards cancer clinical trials

ICORG 10-14: Neo-AEGIS: A randomized clinical trial of neoadjuvant and adjuvant chemotherapy (modified MAGIC regimen) versus neoadjuvant chemoradiation (CROSS protocol) in adenocarcinoma of the esophagus and esophagogastric junction

The RNA-Editing Enzyme ADAR1 Controls Innate Immune Responses to RNA

The Epitranscriptome and Innate Immunity

Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates

Dynamic actuation enhances transport and extends therapeutic lifespan in an implantable drug delivery platform

New Insights into the Biological Role of Mammalian ADARs; the RNA Editing Proteins

Usher Syndrome on the Island of Ireland: A Genotype-Phenotype Review

Suchergebnisse filtern